Babies For Sale
A public service message brought to you by the WebMagician

The Foreskin RE-SALE Industry
Circumcision originated for the express purpose of depriving a man of the incredible sexual pleasure his foreskin was designed to produce. Despite the slight-of-hand attempts doctors make at confusing the issue with medical myths and lies, circumcision continues to be done for precisely this reason.

But there is another force driving the circumcision machinery, and it is an even more insidious one. MONEY. The numbers of dollars involved are staggering, and this financial force is one which is providing the funds to continue the spread of medical propaganda advocating circumcision.

A number of high-tech businesses know unequivocally that infant foreskin is extraordinarily unique. Companies such as Apligraf, Advanced Tissue Sciences, BioSurface Technology, Ortec International, and Organogenisis (and many others) are huge purchasers of infant foreskin tissue.

The May 1998 issue of Business Week provided a glimpse into this sadistic industry. "One piece of foreskin can produce four acres of engineered skin". Skin that sells for more than $3,000.00 a square foot! The February 1998 issue of Wired magazine quotes one of these companies, "The cells from a single foreskin can produce 200,000 units of manufactured skin". "That's enough skin to cover about 250 people."

Other companies also know the value of infant foreskin. Cosmetics companies, such as Estee Lauder, Helene Curtis, and Mary Kay Cosmetics, use babies' foreskins in their test laboratories.
The doctors aren't going to put an end to circumcision - they make huge sums of money to mutilate the babies. The hospitals aren't going to put an end to it - they get paid when they sell the foreskins to the cosmetics and biotech companies. Those commercial companies aren't going to put an end to it - they're making mountains of money churning out commercial consumer products from the tortured suffering of innocent babies. And the government isn't going to stop it - they make money off the product licensing approval fees and the taxes on all the various and sundry 'sales'.

Related reference articles (in no particular order):

Periscope: Bionic Band-Aid
     Newsweek   Wednesday, January 13, 1999

Living Human Skin Equivalent Apligraf
     Molecule of the Month   February 1998

Bioengineered skin wins approval from the FDA
     Wound Care newsletter   July 1998

The Role of Tissue Engineering in Wound Care
     AVF Newsletter   American Venous Forum, Winter 1998

Media Release - Communique Aux Medias - Medienmitteilung
     FDA clears Apligraf (graftskin) for venous leg ulcers   26 May 1998

FDA approves new bioengineered skin
     The Associated Press   Cleveland Live, May 27, 1998

FDA Clears Apligraf™ (graftskin) for Venous Leg Ulcers
     Novartis Pharmaceuticals Corporation   May 26 1998

New Skin
     Mining Co. Guide   January 14, 1999

     Organogenisis Inc.

Organogenesis Inc. may buy back 500,000 shares
     Boston Business Journal   September 14, 1998

Artificial Skin
     Biomedical Engineering: University of Southern California   May 1998

Canada Becomes First Country To Approve Apligraf Tissue
     Newswire   April 1997

Lending a hand: Biotech firm sells body parts
     The Ottawa Citizen   Monday 16 February 1998

Biotech Bodies
     Business Week   July 16, 1998

Biotech Devices Promise Benefits in Wound Repair and Surgery
     Medical Device & Diagnostic Industry Magazine   February 1997

Special report on the tissue engineering and wound healing symposium at the Joint PAN/Asian and ETRS Meeting, 28 - 31 October 1997
     European Tissue Repair Society   27 July 1998

FDA panel urges approval of bioengineered skin
     C-Health News   Thursday, January 29, 1998

This page is still under construction.

WebMagician is a trademark of Eon Systems Corporation - All Rights Reserved
Copyright ©1997-1999 WebMagician - All Rights Reserved
last updated: March 7, 1999
WebSite Design by